Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab
- 7 April 2011
- journal article
- case report
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 21 (6) , 660-664
Abstract
We report the case of a 68-year-old woman with Stage III and Class II rheumatoid arthritis (RA) that was resistant to prednisolone, methotrexate, and infliximab. After treatment with etanercept or tocilizumab, suspicious allergic bronchopulmonary aspergillosis (ABPA) repeatedly occurred and then rapidly improved after the withdrawal of each drug. We suspect that administration of etanercept and tocilizumab caused suspicious ABPA in this patient. The relevance to the pathogenesis of ABPA under these biological drugs is also discussed.Keywords
This publication has 27 references indexed in Scilit:
- Allergic Bronchopulmonary AspergillosisProceedings of the American Thoracic Society, 2010
- IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal AllergensThe Journal of Immunology, 2009
- GP130-STAT3 Regulates Epithelial Cell Migration and Is Required for Repair of the Bronchiolar EpitheliumThe American Journal of Pathology, 2008
- Haemophilus influenza e Lysate Induces Aspects of the Chronic Obstructive Pulmonary Disease PhenotypeAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialThe Lancet, 2008
- Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumabAnnals of the Rheumatic Diseases, 2007
- Biologic therapies in rheumatology: lessons learned, future directionsNature Reviews Drug Discovery, 2007
- Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell TiesImmunity, 2006
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxideAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005